The revolution in breast cancer surgery: Science or anecdotalism? Bernard Fisher OriginalPaper Pages: 655 - 666
The role of radiotherapy following total mastectomy for patients with early breast cancer D. A. BerstockJ. HoughtonM. Baum OriginalPaper Pages: 667 - 670
Mastectomy versus radiotherapy as treatment for stage I-II breast cancer: A prospective randomized trial at the National Cancer Institute P. A. FindlayM. E. LippmanA. S. Lichter OriginalPaper Pages: 671 - 675
Conservative treatment of breast cancer with the QU.A.RT. technique Umberto VeronesiRoberto ZucaliMarcella Del Vecchio OriginalPaper Pages: 676 - 681
Limited surgical management for primary breast cancer: A commentary on the NSABP reports Bernard FisherNorman Wolmark OriginalPaper Pages: 682 - 691
Lumpectomy and axillary dissection for breast cancer: Surgical, pathological, and radiation considerations Bernard FisherNorman WolmarkMelvin Deutsch OriginalPaper Pages: 692 - 698
Adjuvant chemotherapy in stage II breast cancer: A brief overview of the NSABP clinical trials Norman WolmarkBernard Fisher OriginalPaper Pages: 699 - 706
Adjuvant CMF chemotherapy in operable breast cancer: Ten years later Gianni BonadonnaAnna RossiPinuccia Valagussa OriginalPaper Pages: 707 - 713
A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: A CALGB study William C. WoodRaymond B. WeissCancer and Leukemia Group B OriginalPaper Pages: 714 - 718
Adjuvant chemotherapy for operable breast cancer with positive axillary nodes: A comparison of CMFVP versus L-PAM Saul E. RivkinHarold GlucksbergJohn Constanzi OriginalPaper Pages: 719 - 722
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status Saul E. RivkinWilliam A. Knight IIIJohn J. Costanzi OriginalPaper Pages: 723 - 727
Adjuvant chemotherapy in postmenopausal women: Results of sequential noncross-resistant regimens Cristina BrambillaAnna RossiGianni Bonadonna OriginalPaper Pages: 728 - 737
Eight-year follow-up of adjuvant therapy for stage II breast cancer Charles A. HubayNahida H. GordonParticipating Investigators OriginalPaper Pages: 738 - 749
Adjuvant tamoxifen and chemotherapy in stage II breast cancer: Interim findings from NSABP protocol B-09 Norman WolmarkBernard Fisher OriginalPaper Pages: 750 - 755
Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer A. J. WilsonM. BaumS. H. Ellis OriginalPaper Pages: 756 - 764
Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status Carsten RoseHenning T. MouridsenDanish Breast Cancer Cooperative Group OriginalPaper Pages: 765 - 774
The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery Richard A. SoraceCaroline S. BagleyMarc E. Lippman OriginalPaper Pages: 775 - 785
Synchronous multiple early gastric carcinoma: A study of 178 cases Yoshikazu NoguchiHirotoshi OhtaYo Kato Original Scientific Reports Pages: 786 - 792
Seat belt-induced trauma to the small bowel C. ChristophiF. T. McDermottE. S. R. Hughes Original Scientific Reports Pages: 794 - 797
Two techniques of measurement of the delayed hypersensitivity skin test response for the assessment of bacterial host resistance Nicolas V. ChristouGinette BoisvertJonathan L. Meakins Original Scientific Reports Pages: 798 - 804
Median sternotomy in reoperations for primary hyperparathyroidism Jeffrey A. NortonPhilip D. SchneiderMurray F. Brennan Original Scientific Reports Pages: 807 - 812
A comparison of the prophylactic value of cefotetan and metronidazole in appendectomy John A. C. BuckelsRoger BrooksteinJohn Alexander-Williams Original Scientific Reports Pages: 814 - 817
